ArticleJournal of hepato-biliary-pancreatic sciences2026

Histopathologic Subtype as a Determinant of Prognosis and Chemotherapy Benefit in Resected Ampullary Adenocarcinoma.

Riccardo Pellegrini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.